Difficulty: Medium
Average Score: 73%
Practice
The drug contraindicated in children with hypertrophic cardiomyopathy is
Correct answer
C
Rationale
In pediatric nursing, it is crucial to have a deep understanding of drug contraindications to ensure the safety and well-being of young patients. In the context of hypertrophic cardiomyopathy, a condition characterized by abnormal thickening of the heart muscle, the drug contraindicated is Digitalis (Option C).
Digitalis, also known as Digoxin, is a medication commonly used to treat heart conditions by slowing the heart rate and increasing the force of contractions. However, in children with hypertrophic cardiomyopathy, Digitalis can exacerbate the condition by increasing the force of myocardial contraction, leading to potential adverse effects like worsening of left ventricular outflow tract obstruction and arrhythmias.
Antibiotics (Option A) are not inherently contraindicated in children with hypertrophic cardiomyopathy unless there are specific drug interactions to consider. Diuretics (Option B) may actually be beneficial in managing fluid overload in these patients. Immunosuppressives (Option D) are not typically used in the treatment of hypertrophic cardiomyopathy in children.
It is essential for pediatric nurses to be well-versed in pharmacology and understand the implications of drug therapy in various pediatric conditions. This knowledge helps in providing safe and effective care to pediatric patients, especially those with complex cardiac conditions like hypertrophic cardiomyopathy. By selecting the correct medication and being aware of contraindications, nurses can contribute to positive patient outcomes and prevent potential complications.
Digitalis, also known as Digoxin, is a medication commonly used to treat heart conditions by slowing the heart rate and increasing the force of contractions. However, in children with hypertrophic cardiomyopathy, Digitalis can exacerbate the condition by increasing the force of myocardial contraction, leading to potential adverse effects like worsening of left ventricular outflow tract obstruction and arrhythmias.
Antibiotics (Option A) are not inherently contraindicated in children with hypertrophic cardiomyopathy unless there are specific drug interactions to consider. Diuretics (Option B) may actually be beneficial in managing fluid overload in these patients. Immunosuppressives (Option D) are not typically used in the treatment of hypertrophic cardiomyopathy in children.
It is essential for pediatric nurses to be well-versed in pharmacology and understand the implications of drug therapy in various pediatric conditions. This knowledge helps in providing safe and effective care to pediatric patients, especially those with complex cardiac conditions like hypertrophic cardiomyopathy. By selecting the correct medication and being aware of contraindications, nurses can contribute to positive patient outcomes and prevent potential complications.